Stocks
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | |||
| EV/EBITDA | ? | 168.6 | -76.4 | -15.6 | 114.6 | -25.7 | -5.14 | |
| Changes by years, y/y, % | -118% | -145% | -80% | -836% | -122% | |||
Anika Therapeutics. EV/EBITDA
Anika Therapeutics. EV/EBITDA, changes, %
Anika Therapeutics (ANIK) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -35.0 | -81.2 | -189.3 | -12.7 | -14.3 | -5.14 | |
| Changes by years, y/y, % | +46% | +443% | +1 078% | +10% | +24% | |||
| Changes by quarters, q/q, % | +37% | +132% | +133% | -93% | +12% | |||
